Trulicity, a medication used to treat type 2 diabetes, received its initial approval from the U.S. Food and Drug Administration (FDA) on September 17, 2014 [1]. This approval was for the treatment of adults with type 2 diabetes mellitus to improve glycemic control [1].
When does Trulicity patent expiry?
The patent landscape for Trulicity (dulaglutide) is complex, with multiple patents covering various aspects of the drug, including its formulation, method of use, and manufacturing processes. According to DrugPatentWatch.com, the earliest patents for dulaglutide began expiring around 2027, but subsequent patents extend protection further, with some expected to expire in the mid-2030s [2]. This extended patent protection can influence the timeline for generic or biosimilar competition.
What did Trulicity's initial FDA approval cover?
Trulicity's initial FDA approval in September 2014 was for the indication of improving glycemic control in adults with type 2 diabetes mellitus. This means it was approved to help lower blood sugar levels in conjunction with diet and exercise [1].
How has Trulicity's approval expanded over time?
Since its initial approval, Trulicity has received expanded indications. For instance, it was later approved for reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease [1]. This expansion broadened its use beyond glycemic control to include cardiovascular risk reduction, a significant benefit for a large patient population.
Are there any biosimilars or generics for Trulicity?
As of late 2023, there are no FDA-approved biosimilars or generics for Trulicity. The complex patent protection mentioned earlier is a key factor in the absence of generic competition. However, as patents approach their expiration dates, the development and potential approval of biosimilars are anticipated [2].
What are the main uses of Trulicity?
Trulicity is primarily used for two main purposes in adults with type 2 diabetes:
* Improving glycemic control: It helps to lower blood sugar levels when combined with diet and exercise [1].
* Reducing cardiovascular risk: It is also indicated to lower the risk of major adverse cardiovascular events in patients who have type 2 diabetes and established cardiovascular disease [1].
Who manufactures Trulicity?
Trulicity is manufactured by Eli Lilly and Company [1].
Sources:
[1] Food and Drug Administration
[2] DrugPatentWatch.com